ArQule Message Board - Msg: 6887033

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (299)	12/18/1998 6:09:00 AM
From: StockDoc	Read Replies (1) of 399

I don't know who the sucker is: the investors or the company. Hunting at night in sunglasses for flying birds with a new shotgun. This is where this company is. This is where almost all random drug discovery companies are. Selling High throughput screening, unlike experimental research, has the disadvantage of eliminating intelligence from analysis of information. Accordingly, it has never produced anything useful. The discoverer randomly digging in the desert might come across something interesting. The chances are slim. The shovel is patented, OK. But. If I don't shoot, the chances are 0. So, I give it a chance. A moderate one.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next